P/E at 60.48 vs Industry's 66.93: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amidst Sector Premiums

Apollo Hospitals Enterprise Ltd. trades at a P/E multiple of 60.48, which is approximately 9.7% below the hospital industry’s average P/E of 66.93. This discount is intriguing given the company’s stature as a large-cap stock with a market capitalisation of ₹1,27,746.20 crores. The valuation gap suggests that investors may be pricing in a more cautious outlook relative to peers, despite the company’s strong historical performance. The sector’s elevated P/E reflects growth expectations and premium valuations typical of healthcare providers, yet Apollo Hospitals appears to be trading with a degree of restraint — previously rated Buy, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: A Mixed Momentum Story

The stock’s performance over the past year has been robust, delivering a 13.67% gain while the Sensex declined by 8.11%. This outperformance extends over longer horizons, with three-year returns at 74.47% and five-year returns at 85.27%, both significantly ahead of the Sensex’s 10.78% and 27.98% respectively. The ten-year return of 592.83% further underscores the company’s sustained growth trajectory over the past decade.

However, the short-term momentum is less consistent. Over the last three months, Apollo Hospitals gained 4.93%, outperforming the Sensex’s modest decline of 1.46%. Yet, the one-month return shows a slight dip of 0.45%, contrasting with the Sensex’s sharper 3.66% fall. The one-week gain of 0.96% also contrasts with the Sensex’s 0.56% loss, while the one-day performance of 0.39% is marginally below the Sensex’s 0.49% rise. This pattern suggests a recent softening in momentum after a period of relative strength — is this a temporary pause or a sign of shifting investor sentiment?

Moving Average Configuration: Bullish Technical Setup

Technically, Apollo Hospitals is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This comprehensive positioning indicates a strong upward trend and suggests that the stock is in a sustained recovery or continuation phase rather than a breakdown or dead-cat bounce. The recent gain after two consecutive days of decline further supports this positive technical momentum. Such a configuration often signals investor confidence in the near term, although it remains important to monitor if this trend can be maintained amid broader market volatility.

Sector Performance Context: Hospital Industry Trends

The hospital sector has experienced mixed results recently, with a combination of positive, flat, and negative performances across constituent stocks. Apollo Hospitals stands out with its consistent outperformance over the medium and long term, reflecting its leadership position and operational resilience. The sector’s elevated P/E ratio of 66.93 indicates strong growth expectations, yet the discount at which Apollo Hospitals trades may reflect cautiousness around near-term challenges or valuation recalibration. This dynamic is important to consider when analysing the stock’s relative attractiveness within the hospital industry.

Rating Reassessment: Previously Rated Buy

On 10 Sep 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from Buy to a new assessment by MarketsMOJO. While the current rating is not disclosed, the previous Buy rating was supported by strong fundamentals and consistent performance. The reassessment likely reflects the evolving valuation and performance landscape, including the stock’s premium discount relative to the sector and its recent technical strength. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Collective Data Insights: Valuation, Performance, and Technicals

Bringing together the valuation, performance, and technical data, Apollo Hospitals Enterprise Ltd. presents a compelling profile. The stock’s P/E discount relative to the hospital industry suggests a more conservative valuation stance despite its leadership and growth record. Its outperformance over one, three, and five years versus the Sensex highlights sustained operational strength, while the recent short-term momentum and technical positioning above all major moving averages indicate ongoing investor confidence. The rating update from Buy to a new assessment reflects these nuanced factors — what is the current rating for Apollo Hospitals?

In summary, the data reveals a stock that balances a premium valuation environment with measured investor caution, supported by strong long-term returns and a bullish technical setup. This multifaceted picture is essential for understanding Apollo Hospitals’ position within the hospital sector and the broader market landscape.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →